Siteman Cancer Center debuted the first single-vault proton therapy center in the country
On Dec. 19, 2013, the Siteman Cancer Center debuted the first single-vault proton therapy center in the U.S.:…
Genentech drug Gazyva (obinutuzumab) was approved
On Nov. 13, 2013, Genentech announced that it’s drug Gazyva (obinutuzumab) was approved by the U.S. Food and…
Nike co-founder Phil Knight and wife Penny issued $1 billion cancer challenge
On Sept. 21, 2013, philanthropists Phil and Penny Knight pledged $500 million to kick-start a $1 billion cancer…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
The Markey Cancer Center became an NCI-designated Cancer Center
On Jul. 12, 2013. the University of Kentucky Markey Cancer Center (MCC) was joined by national, state and…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
UNMC named new cancer center the Fred & Pamela Buffett Cancer Center
On Jun. 7, 2013, the University of Nebraska Board of Regents approved renaming the UNMC Eppley Cancer Center…
Biotechnology | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics | Women's Health
World Ovarian Cancer Day was established
On May 8, 2013, was the first World Ovarian Cancer Day. On this day, ovarian cancer organizations from…
Biotechnology | Diagnostics | Life Science News | Medicine | NIH | Non-Profit Research | Oncology | Therapeutics
The University of Kansas Cancer Center earned National Cancer Institute designation
On Jul. 12, 2012 the University of Kansas Cancer Center earned National Cancer Institute designation. Through efforts initially…
Genentech drug Perjeta (pertuzumab) was approved
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
Treatment outcomes in black and white children with cancer was published
On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…
Report to the nation finds continuing declines in cancer death rates since the early 1990s
On Mar. 29, 2012, the U.S. Centers for Disease Control and Prevention (CDC) reported that death rates from…
Single antibody shrinks variety of human tumors transplanted into mice, study showed
On March 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
The U.S. FDA approved Erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinoma
On Jan. 30, 2012, the U.S. Food and Drug Administration (FDA) approved Genentech’s Erivedge (vismodegib) capsule, the first…
The UC San Diego Health System acquired the Nevada Cancer Institute
On Jan. 23, 2012, UC San Diego Health System announced it had received approval to acquire the Nevada…
Rock and Roll Hall of Fame inductee Alice Cooper played a benefit concert at OMRF
On Jun. 24, 2012, Rock and Roll Hall of Fame inductee Alice Cooper helped raise $675,500 for the…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Comprehensive Cancer Center received NCI designation
In 2012, The UC Davis Comprehensive Cancer Center received NCI comprehensive cancer designation. The center is a matrix…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Non-Profit Research | Oncology | Therapeutics
Karmanos researcher Patricia LoRusso appointed co-leader of the Stand Up To Cancer Dream Team
On Dec. 14, 2011, Patricia M. LoRusso, D.O., of the Barbara Ann Karmanos Cancer Institute in Detroit, Michigan;…
Genentech drug Zelboraf (vemurafenib) was approved
On Aug. 16, 2011, the U.S. Food and Drug Administration (FDA) approved vemurafenib tablets (Zelboraf, Hoffmann-LaRoche Inc.) for…
Disease | Life Science History | Life Science News | Medicine | Non-Profit Research | Oncology | Radiology | Therapeutics
Siteman Cancer Center performed its 5,000th bone marrow transplant
On Aug. 9, 2011, the Siteman Cancer Center announced that it had performed its 5,000th bone marrow transplant,…
TomoTherapy acquired by Accuray
On Jun. 13, 2011, Accuray announced it had completed its acquisition of TomoTherapy. The combination creates the premier…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
University Hospitals Seidman Cancer Center opened
On Jun. 6, 2011, University Hospitals (UH) Seidman Cancer Center, Northeast Ohio’s first and only freestanding cancer hospital,…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Jon M and Karen Huntsman donated $41 million to cancer research at Huntsman Cancer Institute
On Apr. 21, 2011, Jon M. and Karen Huntsman donated $41 million to cancer research at Huntsman Cancer…
Gilead Sciences acquired Calistoga Pharmaceuticals for $375 Million
On Feb. 22, 2011, Foster City, Calif-based Gilead Sciences and Calistoga Pharmaceuticals announced Gilead’s acquisition of Calistoga for…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Jane and Lee Seidman donated $42 million to University Hospitals for Cancer Center
On Nov. 30, 2010, Jane and Lee Seidman have donated $42 million to University Hospitals (UH) – the…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Non-Profit Research | Oncology | Women's Health
Siteman Cancer Center received NCI SPORE grant to study endometrial cancer
On Mar. 5, 2010, the National Cancer Institute (NCI) announced that it had awarded the Siteman Cancer Center…
Pacific Health Research & Education Institute became successor-in-interest to Pacific Health Research Institute
In 2010, the Pacific Health Research & Education Institute (PHREI) became the successor-in-interest to Pacific Health Research Institute….
The Jon M Huntsman family donated $125 million to the Huntsman Cancer Institute
On Apr. 26, 2000, Jon M. Huntsman, a billionaire industrialist, announced that he would give $125-million to a…
FDA approved new indication for gardasil to prevent genital warts in men and boys
On Oct. 16, 2009, the U.S. Food and Drug Administration (FDA) approved new indication for gardasil to prevent…
Dr. Brian Druker honored with Lasker Award
On Sept. 16, 2009, Brian J. Druker, M.D.,whose research led to the development of Gleevec, the first targeted…
Pfizer collaborated on landmark $6 million oncology research project with the Ontario Institute for Cancer Research
On Jul. 15, 2009, Pfizer with the Ontario Institute for Cancer Research (OICR) and the Ontario Cancer Institute…